ANTXR1 and neoplasm: TEM8 was described in the early 2000s as being highly upregulated in tumor endothelium versus normal endothelium and some tumor cells in many types of tumors, including osteosarcoma, gastric cancer, breast cancer, lung cancer, colorectal cancer, and melanoma [38,70,77].